Your web browser doesn’t have the Flash Player v.9 plugin installed, so this Website can’t be properly viewed.
For full experience, please download the latest Flash plugin at Adobe.com.
Download Adobe Flash Player now.
GARDASIL®
Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine
GARDASIL® AND YOUR SON OR DAUGHTER
GARDASIL® is a vaccine that helps protect against 4 types of HPV: 2 types that cause 70% of cervical cancers in women, and 2 more types that cause 90% of genital wartsGenital wartsGenital warts are usually flesh-coloured growths that are caused by certain types of HPV. Learn more about genital warts.
Get More Information
See Full Glossary in men and women.
GARDASIL® has also been shown to help protect against vulvar and vaginal cancers, as well as abnormal and pre-cancerous cervical cells (as found in abnormal Pap tests) in women.
GARDASIL® is indicated for girls and women ages 9 to 26, and for boys and men ages 9 to 26.
You can help protect your son/daughter from HPV by getting him/her vaccinated with GARDASIL® today
Like other vaccines your son/daughter may have received, GARDASIL® works to help prevent illness. GARDASIL® works best when given before there is any contact with HPV types 6, 11, 16 and 18. That’s why boys and girls as young as 9 can get vaccinated.
GARDASIL® IS RECOMMENDED AS PART OF YOUR DAUGHTER’S VACCINATION SCHEDULE
Look who has supported
HPV vaccination for females:
- The National Advisory Committee
on ImmunizationBy clicking on this link, you will be leaving this siteThis link will take you to a site outside of Merck Frosst Canada Ltd. Merck does not review or control the content of any non-Merck site. Merck does not endorse and is not responsible for the accuracy, content, practices, or standards of any non-Merck site.
Proceed - The Canadian Paediatric SocietyBy clicking on this link, you will be leaving this siteThis link will take you to a site outside of Merck Frosst Canada Ltd. Merck does not review or control the content of any non-Merck site. Merck does not endorse and is not responsible for the accuracy, content, practices, or standards of any non-Merck site.
Proceed - The Society of Obstetricians and Gynaecologists of CanadaBy clicking on this link, you will be leaving this siteThis link will take you to a site outside of Merck Frosst Canada Ltd. Merck does not review or control the content of any non-Merck site. Merck does not endorse and is not responsible for the accuracy, content, practices, or standards of any non-Merck site.
Proceed - Federation of Medical Women
of CanadaBy clicking on this link, you will be leaving this siteThis link will take you to a site outside of Merck Frosst Canada Ltd. Merck does not review or control the content of any non-Merck site. Merck does not endorse and is not responsible for the accuracy, content, practices, or standards of any non-Merck site.
Proceed - The Society of Gynecologic Oncologists of CanadaBy clicking on this link, you will be leaving this siteThis link will take you to a site outside of Merck Frosst Canada Ltd. Merck does not review or control the content of any non-Merck site. Merck does not endorse and is not responsible for the accuracy, content, practices, or standards of any non-Merck site.
Proceed
When you’re ready, you’ll be able to share the facts with him/her. But by getting your daughter vaccinated with GARDASIL® now, you’ll be helping to protect her against 4 types of HPV and the diseases it can cause such as cervical cancer, genital warts, vulvar and vaginal cancers and abnormal and precancerous cervical, vaginal and vulvar cells before she’s old enough to worry about them. By getting your son vaccinated with GARDASIL® now, you’ll be helping to protect him against 4 types of HPV and genital warts caused by types 6 and 11 before he’s old enough to worry about them.
IMPORTANT INFORMATION ABOUT GARDASIL®
GARDASIL® is a vaccine indicated in girls and women 9-26 years of age, for the prevention of infection caused by HPV types 6, 11, 16 and 18, and the following diseases associated with these types: cervical cancer, abnormal and precancerous cervical cells, vulvar and vaginal cancers, abnormal and precancerous vulvar and vaginal cells, and genital warts. GARDASIL® is indicated in boys and men 9-26 years of age for the prevention of infection caused by HPV types 6, 11, 16 and 18, and genital warts caused by HPV types 6 and 11.
GARDASIL® helps prevent these diseases but it does not treat them. And just like all vaccines, GARDASIL® may not fully protect everyone who gets it. GARDASIL® does not protect against all types of HPV. Duration of protection over the long term has not been established. Vaccination with GARDASIL® is not recommended during pregnancy. GARDASIL® may cause side effects and allergic reactions.
Even if you get vaccinated with GARDASIL®, it is still important for women to continue having regular Pap tests.
Only a healthcare professional can decide if GARDASIL® is right for you, your son or your daughter.
Read the Patient Product Information or the Prescribing Information for more information.
This site is intended only for residents of Canada. This Website is for information purposes only.
®Registered Trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Used under license.
©2010 MERCK FROSST CANADA LTD. All rights reserved.
08-11-HPV-10-CDN-84140662-AV
